MHT has been associated with lower BMI, higher age, smaller tumor size, higher frequency of lobular tumors (22, 25, 26), tumor estrogen receptor (ER) positivity (14, 26), and screening detection (27), i.e., several less aggressive tumor characteristics. This evidence concerns the gene ESR1 and neoplasm.